Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)

Tobias Welte, Antoní Torres, Jean‐Louis Vincent et al.|Intensive Care Medicine|2018

Cited by 136